NYSE:CRLLife Sciences
Charles River (CRL) Stock Jumps As Margin Repair Meets Valuation Doubt
Charles River Laboratories International jumped 11.4% to US$260.72 on Wednesday as investors rushed to reprice a story that now looks less about survival and more about repair. The headline is simple. Q2 non GAAP earnings came in strong enough for management to lift full year earnings guidance and discuss a cleaner portfolio and better margin run rate.
Short term traders see a sharp move in a stock that had already logged a solid 90 day run. Longer term holders are now weighing that rally...